Use of HeartWare Ventricular Assist System for Systemic Ventricular Support of a Pediatric Patient After Mustard Procedure. (April 2015)

• Record Type: Journal Article
• Authors: Kenleigh, Dorian; Edens, R. Erik; Bates, Michael J.; Turek, Joseph W.
• Is Part Of: World journal for pediatric & congenital heart surgery. Volume 6:Number 2(2015:Apr.)
• Page Start: 339
• Page End: 341
• Publication Date: 2015-04
• Subjects: circulatory assist devices (LVAD, RVAD, BVAD, TAH) -- circulatory hemodynamics -- congenital heart disease -- congenital heart surgery -- arterial switch operation -- heart failure -- pediatric -- transplantation -- heart -- adult congenital heart disease -- artificial organs; Pediatric cardiology -- Periodicals; Congenital heart disease in children -- Periodicals; Heart -- Abnormalities -- Surgery -- Periodicals; Heart -- Surgery -- Periodicals; Heart Defects, Congenital -- surgery -- Periodicals; Cardiac Surgical Procedures -- Periodicals; Child -- Periodicals; Adult -- Periodicals; 618.9212
• DOI: 10.1177/2150135114563769
• Languages: English
• ISSNs: 2150-1351

Abstract

Background: The HeartWare Ventricular Assist System is indicated to provide mechanical circulatory support of patients with intractable heart failure as a bridge to cardiac transplantation. We describe the use of this device to support the systemic right ventricle (RV) of a pediatric patient with New York Heart Association class IIIC congestive heart failure who had undergone Mustard procedure for D-transposition of the great vessels as an infant. Case report: A HeartWare ventricular assist device was implanted in the left chest of a 16-year-old female patient (body surface area 1.43 m 2 ) who presented with edema and later deteriorated, developing acute kidney injury, dysrhythmia, and pulmonary edema. Results: The patient's edema and acute kidney injury resolved after device placement. She was discharged home and successfully underwent device removal with heart transplant five months later. Conclusion: The HeartWare device may be used for extended support as a systemic RV in a pediatric patient. It is feasible to consider using the device in this patient population.